Global Gene Amplification Detector Devices Market, By Technology (PCR-Based Amplification, Target Amplification, Signal Amplification, Isothermal DNA Amplification, Cycling Temperature DNA Amplification, Isothermal Signal Amplification, Cycling Temperature Signal Gene Amplification, Exponential Gene Amplification, Linear Gene Amplification), Application (Forensics, Paternity, Identity, Food Safety, Agri-Diagnostics, Veterinary) – Industry Trends and Forecast to 2029.
Gene Amplification Detector Devices Market Analysis and Size
Gene amplification is the differential increase in a specific portion of the genome compared to the rest of the genome. This process appears to be ubiquitous, occurring in most organisms and has also been demonstrated to occur in germline and somatic cells. Gene amplification can occur as a result of normal developmental processes or as a result of sporadic genetic events with either beneficial (for instance, growth or survival advantage) or detrimental (for instance, tumorigenesis) consequences for the organism.
Data Bridge Market Research analyses that the gene amplification detector devices market which is expected a healthy CAGR during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Gene Amplification Detector Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Technology (Target Amplification, Signal Amplification, Isothermal DNA Amplification, Cycling Temperature DNA Amplification, Isothermal Signal Amplification, Cycling Temperature Signal Gene Amplification, Exponential Gene Amplification, Linear Gene Amplification), Application (Forensics, Paternity, Identity, Food Safety, Agri-Diagnostics, Veterinary)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Abbott (U.S.), QIAGEN N.V. (Germany), Agilent Technologies Inc. (U.S.), Bayer AG (Germany), Rubicon Genomics (U.S.), BD (U.S.), F. Hoffmann-La Roche AG (Switzerland), Digene Corporation (U.S.), bioMérieux (France), Bio-Rad Laboratories, Inc. (U.S.), Cepheid (U.S.) and Takara Bio, Inc. (Japan)
|
|
Market Opportunities
|
|
Market Definition
Gene amplification is the differential increase in a specific portion of the genome in comparison to the rest of the genome. This process appears to be ubiquitous, occurring in most organisms and has been shown to occur in both germline and somatic cells.
Global Gene Amplification Detector Devices Market Dynamics
Drivers
- Rising research and development activities
There is a growing emphasis on research and development in the fields of molecular diagnostics, drug discovery, genetic testing, toxicology, environmental monitoring, animal husbandry, bioremediation, forensics, and food quality control. These are the certain factors which will propel the growth of the market.
- Technological advancements
Advances in molecular diagnostic tools, such as NGS, droplet digital PCR, and genome-wide sequencing, have influenced market adoption of gene multiplication techniques in terms of reproducibility, accuracy, and timeliness. Furthermore, global initiatives such as the Africa Pathogen Genomics Initiative (Africa PGI) have fuelled the gene multiplication technology market. In October 2020, this initiative was launched to expand genomics-based public health pathogen surveillance.
Opportunities
- Rising investments in genomics
Increased investment in genomics by pharmaceutical and biotechnology companies is expected to significantly drive the market in the near future. In recent years, the biotechnology industry has seen a significant shift toward new drugs and treatments, genome sequencing-based medicines, and technological advancements, propelling market growth.
Restraints/Challenges
- High cost of detector
High cost coupled with the product, machine is costly and requires expertise for data normalization and analysis will obstruct the market's growth rate.
This gene amplification detector devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the gene amplification detector devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Gene Amplification Detector Devices Market
The Covid-19 pandemic had a significant impact on the global market for gene amplification technologies. The Covid-19 outbreak caused widespread panic and put strain on the healthcare system. As a result, rapid testing was required to halt the spread, and companies also launched Covid-19 detection kits, positively impacting the market. For instance, the United States Food and Drug Administration (FDA) approved an Emergency Use Authorization (EUA) for their breakthrough direct sample addition Covid-19 test on July 1st, 2021.
Recent developments
- In April 2021, Hologic acquired the Finnish-French molecular test maker Mobidiag to meet the growing COVID-19 diagnostic demand.
Global Gene Amplification Detector Devices Market Scope
The gene amplification detector devices market is segmented on the basis of technology and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
- Target Amplification
- Signal Amplification
- Isothermal DNA Amplification
- Cycling Temperature DNA Amplification
- Isothermal Signal Amplification
- Cycling Temperature Signal Gene Amplification
- Exponential Gene Amplification
- Linear Gene Amplification
- PCR-Based Amplification
Application
- Forensics
- Paternity
- Identity
- Food Safety
- Agri-Diagnostics
- Veterinary
Gene Amplification Detector Devices Market Regional Analysis/Insights
The gene amplification detector devices market is analysed and market size insights and trends are provided by country, technology and application as referenced above.
The countries covered in the gene amplification detector devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the gene amplification detector devices market due to the rising investments in healthcare infrastructures, technological advancements and availability of government funds.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the favourable government initiative towards the advancement of healthcare infrastructure.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The gene amplification detector devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for gene amplification detector devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the gene amplification detector devices market. The data is available for historic period 2010-2020.
Competitive Landscape and Gene Amplification Detector Devices Market Share Analysis
The gene amplification detector devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to gene amplification detector devices market.
Some of the major players operating in the gene amplification detector devices market are:
- Abbott (U.S.)
- QIAGEN N.V. (Germany)
- Agilent Technologies Inc. (U.S.)
- Bayer AG (Germany)
- Rubicon Genomics (U.S.)
- BD (U.S.)
- F. Hoffmann-La Roche AG (Switzerland)
- Digene Corporation (U.S.)
- bioMérieux (France)
- Bio-Rad Laboratories, Inc. (U.S.)
- Cepheid (U.S.)
- Takara Bio, Inc. (Japan)
SKU-